-+ 0.00%
-+ 0.00%
-+ 0.00%

Deutsche Bank Downgrades Elevance Health to Hold, Lowers Price Target to $320

Benzinga·12/19/2025 17:29:20
語音播報
Deutsche Bank analyst George Hill downgrades Elevance Health (NYSE:ELV) from Buy to Hold and lowers the price target from $332 to $320.